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HIGHLIGHTS
• A simple and convenient graphene bio‑interface was designed by using multifunctional nano‑denatured bovine serum albumin (nano‑
dBSA) film.
• Highly sensitive cancer biomarker detection in diluted serum at the femtogram per milliliter level was achieved using the nano‑dBSA 
functionalized graphene field‑effect transistor.
ABSTRACT A simple, convenient, and highly sensitive bio‑interface for graphene 
field‑effect transistors (GFETs) based on multifunctional nano‑denatured bovine 
serum albumin (nano‑dBSA) functionalization was developed to target cancer bio‑
markers. The novel graphene–protein bioelectronic interface was constructed by 
heating to denature native BSA on the graphene substrate surface. The formed nano‑
dBSA film served as the cross‑linker to immobilize monoclonal antibody against car‑
cinoembryonic antigen (anti‑CEA mAb) on the graphene channel activated by EDC 
and Sulfo‑NHS. The nano‑dBSA film worked as a self‑protecting layer of graphene 
to prevent surface contamination by lithographic processing. The improved GFET 
biosensor exhibited good specificity and high sensitivity toward the target at an ultralow concentration of 337.58 fg mL−1. The electrical 
detection of the binding of CEA followed the Hill model for ligand–receptor interaction, indicating the negative binding cooperativity 
between CEA and anti‑CEA mAb with a dissociation constant of 6.82 × 10−10 M. The multifunctional nano‑dBSA functionalization can 
confer a new function to graphene‑like 2D nanomaterials and provide a promising bio‑functionalization method for clinical application 
in biosensing, nanomedicine, and drug delivery.
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1 Introduction
Cancer is a major public health problem worldwide. For 
many cancers, it can take 20–30 years for initial lesions to 
progress to late‑stage disease [1]. Early detection is the key 
to cancer control, especially in reducing incidence rates and 
cancer‑related deaths [2]. Cancer protein biomarkers have 
been widely used in the early diagnosis of cancer. Carci‑
noembryonic antigen (CEA) is one of the most commonly 
used specific blood‑based biomarkers for clinical tumor 
diagnosis. CEA is routinely used as an important indicator 
in annual medical checkups in many countries [3]. Serum 
CEA concentration is closely correlated with malignant 
tumors, such as colorectal cancer [4], gastric cancer [5], 
medullary thyroid cancer [6], lung cancer [7], and pancre‑
atic carcinoma [8]. Determination of CEA concentration in 
a clinical sample can provide information about the severity 
of disease, tumor stage, pathological type, tumor metastasis, 
prognosis, and recurrence. Thus, CEA detection is valuable 
for the early diagnosis of cancer and has spurred efforts 
to develop strategies for the highly sensitive detection of 
CEA. The different strategies include photoelectrochemi‑
cal immunosensors [9], time‑resolved fluoroimmunoassay 
[10], surface‑enhanced Raman scattering [11], fluorescence 
resonance energy transfer biosensors [12], electrochemical 
immunosensors [13], and electrochemiluminescence immu‑
nosensors [14, 15]. However, the development of a simple, 
low‑cost, label‑free, and rapid monitoring platform for the 
detection of cancer biomarkers for clinical diagnosis and 
screening applications remains a compelling goal.
Electrical detection of biomolecules based on their 
intrinsic charges is an efficient and ultrasensitive detection 
approach. Specifically, field‑effect transistor (FET) biosen‑
sors are attractive because of their portability, inexpensive 
mass production, low power consumption, label‑free detec‑
tion, rapid response, and the potential for on‑chip integration 
of the sensor and the electronic measurement system [16, 
17]. In a FET biosensor, specific receptors immobilized in 
the sensing channel selectively capture the desired target bio‑
molecules. The captured charged biomolecules can generate 
a doping or gating effect on the channel [18–21]. Both are 
converted into a readable electrical signal by the FET, usu‑
ally as a drain‑to‑source current or channel transconductance.
Interfacing biomolecules with channel sensing materi‑
als is a critical challenge to fabricate high‑performance 
and inexpensive FET biosensors [22, 23]. In particular, the 
emergence of two‑dimensional (2D) nanomaterials, such 
as graphene [24–26], molybdenum disulfide [27, 28], and 
black phosphorus [29], offers new powerful diagnostic tools 
for in vitro diagnosis and biomedical science applications. 
Graphene and graphene derivatives have been widely used 
in protein biomarker detection because of their tunable opti‑
cal properties, high specific surface area, good biocompat‑
ibility, and easy functionalization [30–34]. Furthermore, the 
ambipolar field‑effect, exceptional electrical properties, and 
atomically thin structures make graphene very promising as a 
channel material for FET biosensors [35], because of its excel‑
lent electrostatic coupling with charged target biomolecules.
The specificity and action of these biosensors depend on 
the coupling of effective recognition components on the 
graphene surface through noncovalent interactions that will 
not damage the graphene lattice or degrade its electronic 
performance. Noncovalent linkers mainly exploit π‑stacking 
interactions and hydrophobic forces to attach directly on 
the graphene surface [36]. Bifunctional noncovalent link‑
ers, such as 1‑pyrenebutanoic acid succinimidyl ester, 
N‑hydroxysuccinimide (NHS) ester tripod, bovine serum 
albumin (BSA), pyrene butyric acid, and gold nanoparticles, 
have been successfully used to construct a bio‑interface of 
graphene FET biosensors for the detection of glucose [37], 
DNA molecules [16], single‑nucleotide polymorphisms 
[38], proteins [17, 39–41], and other biochemicals [42, 43]. 
Studies have focused on many difficult problems and topics. 
However, the complex and uncontrollable bio‑interface of 
graphene FET channels remains a hurdle.
Herein, a simple and one‑step method using multifunc‑
tional nano‑denatured BSA (nano‑dBSA) film to construct 
a graphene FET biosensor is described. The system enables 
the highly sensitive detection of cancer biomarkers. To con‑
struct the biosensor, native BSA protein solution was dena‑
tured by heating on graphene to form a layer that protected 
from unexpected destruction and surface contamination. At 
the same time, this nano‑dBSA film could also serve as a 
cross‑linker for the immobilization of anti‑CEA monoclo‑
nal antibody (mAb). With the integration of the denatura‑
tion process into the fabrication of a graphene FET and the 
enriched chemical groups on the dBSA surface, one‑step 
modification using 1‑ethyl‑3‑(3‑dimethylaminopropyl)‑
carbodiimide (EDC)/sulfo‑NHS immobilized receptors on 
the graphene channel. In addition, enhanced sensitivity of 
the graphene FET biosensor was achieved by exploiting 
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the dBSA modification method. Field‑induced sensitivities 
to various CEA concentrations were observed, ultimately 
resulting in good specific recognition of CEA in diluted 
serum at an ultralow concentration of 337.58 fg mL−1. The 
cooperativity and strong affinity between CEA and anti‑CEA 
mAb were estimated by the Hill model. The electric detec‑
tion of the binding of CEA was interpreted to follow the Hill 
model for ligand–receptor interaction, indicating the nega‑
tive cooperativity in binding between CEA and anti‑CEA 
mAb with a dissociation constant of 6.82 × 10−10 M.
The demonstration of multifunctional nano‑BSA chemical 
functionalization provides new functions for graphene‑like 
2D nanomaterials for further applications, such as biosensing, 
nanomedicine, imaging, cancer therapy, and drug delivery.
2  Experimental
2.1  Materials
Graphene films grown by chemical vapor deposition on 
copper foil were purchased from 2D Carbon (Changzhou, 
China). BSA was obtained from Sangon Biotech (Shang‑
hai, China, Purity: > 96%). The EDC and sulfo‑NHS cross‑
linkers were purchased from Sigma‑Aldrich (Darmstadt, 
Germany). Anti‑CEA  mAb1 and anti‑CEA  mAb2 were pur‑
chased from Medix Biochemica (Kauniainen, Finland). CEA 
protein and squamous cell carcinoma (SCC) were obtained 
from Fitzgerald (Acton, MA, USA) and Linc‑Bio Science 
(Shanghai, China), respectively. Cytokeratin‑19‑fragment 
(CYFRA21‑1) was purchased from Calbioreagents (Fos‑
ter City, CA, USA). Quantum dots (QDs) with an emission 
wavelength of 625 nm were from Jiayuan Quantum Dot Co. 
(Wuhan, China). 1‑Pyrenebutyric acid N‑hydroxysuccinim‑
ide ester (PYR‑NHS) was obtained from AnaSpec (Fremont, 
CA, USA). Polydimethylsiloxane (PDMS) was used to fab‑
ricate the reactive chamber. Deionized water obtained from 
a Millipore‑Q purification system (Millipore, Billerica, MA, 
USA) was used for the preparation of all solutions.
2.2  Graphene Device Fabrication
Photoresist was used to define the drain/source electrode 
on a 300‑nm  SiO2/Si substrate, followed by the deposition 
of titanium and gold metals by electron beam evaporation. 
The metals on the photoresist were removed using acetone. 
The graphene‑coated copper foil was etched using aqueous 
ammonium persulfate (10 g mL−1). Graphene was coated on 
the metal electrodes. Native BSA films were denatured on 
the graphene at 80 °C for 3 min, and the remaining dBSA/
graphene films were etched using  O2 plasma for 5 min. 
Finally, SU‑8 photoresist was coated on the films as the 
insulating layer to prevent leakage current. The thickness 
of the dBSA functionalized graphene channel was optically 
characterized.
2.3  Bioprobe Functionalization and Characterization
The functionalization of dBSA on the graphene was car‑
ried out in a reactive chamber. The concentration of anti‑
CEA mAb used for immobilization onto the dBSA film was 
2 mg mL−1. The dBSA film was incubated with 5 mg mL−1 
EDC, 1 mg mL−1 NHS, and anti‑CEA mAb solution in the 
dark. After incubation, the remaining unconjugated antibod‑
ies were removed by rinsing with phosphate buffered saline 
(PBS). A 1% BSA solution was used to block the excess 
reactive groups remaining on the graphene surface for 1 h. 
Secondary anti‑CEA mAb was labeled with QDs (100 nM) 
mixed with 100 ng mL−1 CEA solution. The mixed solution 
was incubated with anti‑CEA‑dBSA functionalized gra‑
phene and bare dBSA functionalized graphene for 1 h each. 
Finally, the fluorescent images of each dBSA functionalized 
graphene were recorded using a fluorescence microscope.
2.4  Measurements
All electrical measurements were performed using a semi‑
conductor parameter analyzer (Keithley 4200).
3  Results and Discussion
3.1  Fabrication of Nano‑BSA Graphene FET
Titanium and gold were patterned on the  SiO2/Si substrate 
as source and drain electrodes by photolithography, metal 
deposition, and a liftoff process, as shown in Fig. 1a, b. Gra‑
phene grown by chemical vapor deposition was transferred 
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to the metal electrodes on the substrate, and the poly(methyl 
methacrylate) film on the graphene was removed by acetone 
(Fig. 1c). Based on denatured BSA‑doped graphene [39], 
native BSA dissolved in deionized water at a concentration 
of 1.5 mM was then dropped on the graphene (Fig. 1d) and 
the native BSA was denatured on the graphene surface at 
80 °C, as shown in Fig. 1e. Obvious thin dBSA films were 
formed on graphene via noncovalent interactions, consist‑
ent with previous observations [44]. The dBSA function‑
alized graphene was defined by photolithography (Fig. 1f) 
and simultaneously etched using  O2 plasma. The photoresist 
was removed by acetone (Fig. 1g). The dBSA functional‑
ized graphene channel was 60 µm in width and 30 µm in 
length. The thickness of this channel measured optically 
was approximately 26.4 nm (Fig. S1). This multifunctional 
nano‑dBSA film acted to prevent surface contamination and 
destruction of the graphene, and also functioned as a cross‑
linker between the graphene FET biosensor and bioconju‑
gate receptor. Finally, to protect the gold contacts from the 

























































Fig. 1  Fabrication of nano‑dBSA functionalized GFET. a Silicon (Si)O2/Si substrate and b titanium/gold electrodes were patterned as source/
drain electrode. c Graphene was transferred onto the metal electrodes. d Native BSA solution was dropped onto the graphene. e Native BSA was 
denatured on the graphene at 80 °C. f Photoresist was used to define the dBSA functionalized graphene channel. g  O2 plasma was used to etch 
the dBSA film and graphene at the same time. h Substrate was coated with SU‑8 photoresist as an insulating layer
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contacts to the electrolyte, a layer of chemically stable SU‑8 
photoresist was coated on the gold electrodes (Fig. 1h).
3.2  Functionalization and Characterization 
of Bioprobes Based on Nano‑dBSA Film
To achieve sensitive CEA recognition, the functionalized 
dBSA film enriched with chemical groups was used as 
a cross‑linker of graphene. The film interacted with the 
graphene by π–π stacking. Anti‑CEA mAb antibodies were 
conjugated onto the dBSA films via an immobilization 
procedure involving EDC and sulfo‑NHS. EDC reacted 
with anti‑CEA mAb to create an o‑acylisourea intermedi‑
ate, and a sulfo‑NHS ester intermediate was formed by 
adding the sulfo‑NHS, which could couple with amine‑
containing dBSA film on graphene. The resulting anti‑
CEA‑dBSA functionalized graphene FETs (GFETs) acted 
as sensitive bio‑interfaces to specifically recognize CEA. 
After immobilizing anti‑CEA mAb and rinsing with PBS, 
native BSA solution was added to the channel of the dBSA 
functionalized GFET to block the excess reactive groups 
remaining on the dBSA surface. Finally, anti‑CEA‑dBSA 
functionalized GFETs were rinsed with deionized water 
and prepared for subsequent detection of target molecules. 
The entire process of the modification for anti‑CEA‑dBSA 
functionalized GFETs is shown in Fig. 2a.
Sandwich fluorescent immunoassay is a commonly used 
approach in biotechnology [45]. It was used to character‑
ize the immobilization of anti‑CEA mAb on dBSA film 
in this study. Secondary anti‑CEA mAb conjugated with 
QDs was mixed with CEA solution and incubated with 
anti‑CEA‑dBSA functionalized graphene and bare dBSA 
functionalized graphene. Compared with the control group, 
the fluorescent images shown in Fig. S2 revealed that anti‑























































Fig. 2  a Processes of the modification for anti‑CEA‑dBSA functionalized graphene. b Schematic diagram of electrolyte‑gated anti‑CEA‑dBSA 
functionalized GFET. c Optical micrograph of the graphene channel
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functionalized graphene surface by the activation of EDC 
and sulfo‑NHS. The results indicated that this novel method 
based on the dBSA film could be effective in the design of 
graphene biosensors.
3.3  Construction of Electrolyte‑Gated Anti‑CEA‑dBSA 
Functionalized GFET
The reaction chamber made of polydimethylsiloxane was 
anchored on the substrate using silicone. The miniaturized 
Ag/AgCl electrochemical reference electrode was immersed 
in the reactive chamber as the gate of the anti‑CEA‑dBSA 
functionalized GFET. Drain–source voltage (Vds) and 
gate–source voltage (Vgs) were applied to force the operation 
of the devices. One terminal of the miniaturized Ag/AgCl 
electrochemical reference electrode was fixed on the shelf, 
and another terminal was immersed in the reactive chamber 
as the gate. Considering the sensitivity of anti‑CEA‑dBSA 
functionalized GFETs, 0.1 mM PBS was added to the reac‑
tive chamber as the electrolyte to maintain an appropriate 
Debye length [46]. A schematic diagram of electrolyte‑gated 
anti‑CEA‑dBSA functionalized GFET is shown in Fig. 2b. 
In addition, a representative optical micrograph of the dBSA 
functionalized graphene channel with an SU‑8 insulating 
layer is shown in Fig. 2c.
3.4  Enhanced Performance of Anti‑CEA‑dBSA 
Functionalized GFET
The performances of electrolyte‑gated anti‑CEA‑dBSA 
functionalized GFETs were evaluated by the fundamental 
measurements of GFETs. The transfer characteristics were 
shown in Fig. 3a, which depicted the successful function‑
alization of nano‑dBSA films on graphene and anti‑CEAs 
mAb with the retention of the intrinsic property of graphene. 
The ambipolar curves indicating the Dirac points (denoted 
VD) at Vgs were between 0.1 and 0.25 V, while Vds was below 
0.2 V, suggesting that the anti‑CEA‑dBSA functionalized 
Gr can be classified as the p‑type. A greater difference was 
observed between two neighboring drain–source currents 
(Ids) in the hole regime (the gate–source voltage was denoted 
Vgs, Vgs < VD) than in the electron regime (Vgs < VD), indicat‑
ing that the gate voltage in the hole regime could be a better 
choice for the detection of target molecules. To maintain 
the performance of the electrodes and graphene channel, a 
low Vds at 0.1 V was applied to drive the anti‑CEA‑dBSA 
functionalized GFET [47].
The transconductance parameter gm for a transistor device 
is widely used to describe FET devices. This parameter rep‑
resents the amplification capability of GFETs [26, 48], where 
a higher  gm enables a greater conductivity response per unit 
of biomolecule charge excitation. Therefore, this parameter 
is positively correlated with the device sensitivity and is 
valuable for sensing applications. The transconductance gm 
of anti‑CEA‑dBSA functionalized GFETs under different 
drain–sources voltages is defined as the derivative of Ids with 
respect to Vgs in Fig. 3b. While the Vds was set at 0.1 V, 
gm = –577.78 μS approached the maximum (denoted gmax−) 
in the hole regime at a special gate voltage Vgs = 0.07 V 
(denoted Vmax‑). Similarly, at Vgs = 0.24 V (denoted Vmax+), 
gm = 434 μS approached another maximum (denoted gmax+) 
in the electron regime. The average transconductance value 
of several anti‑CEA‑dBSA modified GFETs in Table S1 was 
higher than that of the anti‑CEA mAb PYR‑NHS modified 
GFETs in Table S2 and many other reported electrolyte‑
gated GFET devices [26, 49, 50], which revealed the high 
sensitivity of this device for biomolecule detection.
For detailed investigation of the transconductance 
enhancement mechanism, the hole and electron mobility 
parameters of the anti‑CEA‑dBSA functionalized GFETs 
were calculated according to the transconductance gm using 
Eq. (1) [51]:
where L is the channel length, W is the channel width, Ctot 
is the gating capacitance per unit channel area (F  cm−2), 
Vds is the source–drain voltage (V), and gm is the differen‑
tial transconductance. For the interfacial capacitance of the 
graphene–water interface, the quantum capacitance CQ of 
graphene and the double‑layer capacitance Cdl of the elec‑
trolyte are in series connection to construct the gate capaci‑
tance. Subsequently, according to the capacitive equivalent 
circuit model of the graphene conducting channel shown 
in the insert of Fig. 3a, the total gating capacitance per unit 
area is calculated as: Ctot = CQCdl/(CQ + Cdl). The double‑
layer capacitance Cdl acts as a parallel‑plate capacitor, which 
could be calculated using equation: Cdl = 0r∕ddl , where 
0 is the permittivity of free space, r is the dielectric con‑
stant of the electrolyte (~ 78), and ddl is the Debye length on 
the bio‑interface. According to the buffer ionic strength of 
the electrolyte, the Debye length is estimated to be approxi‑
mately 23 nm, and the corresponding double‑layer capaci‑
tance Cdl is approximately 2.97 μF  cm−2. While the graphene 
(1) = gmL∕WCtotVds
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channel potential is Vch, the quantum capacitance CQ of Gr 
is defined as [26, 52]:
where q = − 1.602 × 10−19 C is the electron charge, 
KB = 1.381 × 10−23 J  K−1 is the Boltzmann constant, 
h = 6.626 × 10−34 JS is the Planck constant, vF = 1.1 × 106 
m s−1 is the Fermi velocity of Dirac fermions, and T = 300 K 
at room temperature. The potential distribution in the elec‑
trolyte‑gated anti‑CEA‑dBSA modified GFET device is 
described as Eq. (3) [53]:
where Vgs is the gate–source voltage. Thus, the CQ value at 
an arbitrarily given Vgs can be analytically determined by 




















Using this model for the interfacial capacitance, the 
field‑effect mobility of charge carriers in the device can be 
obtained. The mobility values extracted at the transconduct‑
ance maximum points (gmax− for holes, gmax+ for electrons) 
were used as the mobility parameters of anti‑CEA mAb 
modified GFET devices. Average values of hole mobility 
μave‑h1 and electron mobility μave‑e1 for seven anti‑CEA‑
dBSA GFET devices were estimated to be approximately 
2763.9 and 1169.6 cm2  V−1 s−1, respectively. As shown in 
Fig. 3c, d, the average mobility parameters of several anti‑
CEA mAb functionalized GFET devices based on a nonco‑
valent functionalized linker (PYR‑NHS) were lower than 
those of anti‑CEA‑dBSA GFET devices. These results indi‑
cated that GFET biosensors based on this multifunctional 
and self‑protecting dBSA film could improve the perfor‑
mance of GFET biosensors.
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Fig. 3  a Transfer characteristics of the anti‑CEA‑dBSA functionalized GFET. The insert in a is the capacitive equivalent circuit model of the 
graphene conducting channel. b Anti‑CEA‑dBSA functionalized GFET at different drain–source voltages was defined as the derivative of Ids 
with respect to Vgs. c Hole mobility of anti‑CEA‑dBSA functionalized GFET and anti‑CEA mAb PYR‑NHS functionalized GFET. d Electron 
mobility of anti‑CEA‑DBSA functionalized GFET and anti‑CEA mAb PYR‑NHS functionalized GFET
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3.5  Performance of Anti‑CEA‑dBSA Functionalized 
GFET
The output characteristic curves were obtained by recording 
the Ids versus Vds under different Vgs, as shown in Fig. 4a. The 
dependence of the Ids with Vds variation (− 0.5–0.1 V) veri‑
fied the good electrical contact between the graphene and 
gold electrode. The leakage currents were recorded under 
different top gate voltages (Fig. 4b). Compared with the val‑
ues of the net change in drain currents, the absolute values 
of leakage currents were always below 80 nA, which could 
be considered negligible. To preclude false signals, espe‑
cially those arising from nonspecific binding, several control 
groups were used to assess the utility of the anti‑CEA‑dBSA 
functionalized GFET. The responses of the drain–source cur‑
rent (Ids) after adding the same value (10 ng mL−1) of con‑
trol, cytokeratin‑19‑fragment (CYFRA21‑1), SCC, and CEA 
are shown in Fig. 4c. The general serum diluent was used to 
dilute the biomarkers, which served as the control group at 
the same time. As shown in the specific detection curves of 
the anti‑CEA mAb functionalized GFET in Fig. 4c, when 
the control group, CYFRA21‑1, and SCC were added to the 
buffer solution of the anti‑CEA mAb functionalized GFET, 
no obvious increase was shown in Ids. Upon the addition of 
the CEA protein, a large increase in drain current caused by 
the binding of CEA was observed. To accelerate the reaction 
between the anti‑CEA mAb and CEA protein, the solution 
was stirred for several seconds after the addition of each 
protein. The isoelectric point of CEA was approximately 
4.4–4.7 [54], indicating that these target molecules were 
negatively charged in the nearly neutral pH buffer solution. 
These results demonstrated that the negatively charged CEA 
protein was avidly bound by the anti‑CEA‑dBSA function‑
alized GFET, resulting in an increase in the drain–source 
current upon addition of CEA. Interestingly, the addition of 
control proteins SCC and CYFRA21‑1 did not induce a sim‑
ilar increase in drain–source current, which indicated that 
the nonspecific binding of dBSA functionalized graphene 
with nontarget proteins could be negligible. Taken together, 
the findings indicated that anti‑CEA mAb functionalized 
GFETs exhibited good specificity for the detection of CEA.
The drain–source current of the anti‑CEA‑dBSA func‑
tionalized GFET was monitored at various CEA protein 
concentrations to evaluate its sensing characteristics. The 
Vgs = −0.5 V
Vgs = −0.4 V
Vgs = −0.3 V
Vgs = −0.2 V
Vgs = −0.1 V
Vgs = 0 V
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Fig. 4  a Output characteristics of the anti‑CEA‑dBSA functionalized GFET. b Leakage current of the anti‑CEA‑dBSA functionalized GFET. 
c Drain–source current curve responses to control group, CYFRA21‑1, SCC, and CEA. d Monitoring of drain–source current with increasing 
CEA concentrations (10 pg mL−1, 100 pg mL−1, 1 ng mL−1, 10 ng mL−1, and 100 ng mL−1)
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target CEA proteins at concentrations of 10  pg  mL−1, 
100 pg mL−1, 1 ng mL−1, 10 ng mL−1, and 100 ng mL−1 
were introduced into the channel of the anti‑CEA‑dBSA 
functionalized GFET as the time‑dependent response of 
the drain current was recorded (Fig. 4d). The mechanism 
of detection for anti‑CEA‑dBSA functionalized GFETs 
involved the adsorption of negative CEA proteins on the 
surface of the graphene. These proteins acted as electron 
donors, resulting in conductance changes. For this reason, 
the drain–source current increased gradually after injection 
of the target CEA at each concentration (Fig. 4d). According 
to the response of the control group, the limit of detection 
was less than 56 fM.
3.6  Target Detection in Diluted Serum Samples
Analysis of clinically relevant samples, such as blood serum, 
could be very important in the clinical diagnosis of cancer. 
To verify target detection in serum samples using the anti‑
CEA‑dBSA functionalized GFET, the target CEA proteins 
in diluted blood serum at concentrations of 10 pg mL−1, 
100 pg mL−1, 1 ng mL−1, 5 ng mL−1, and 45 ng mL−1 were 
added to the reactive chamber, and the drain–source cur‑
rent was recorded at the same time. As shown in Fig. 5a, 
the drain–source currents increased with the target molecule 
concentrations. The gradually increasing drain–source cur‑
rent response with increasing CEA concentration in blood 
serum was consistent with the results in Fig. 4d. The general 
serum diluent was used to dilute the CEA‑containing serum 
sample, which also worked as a control group.
The average net drain–source currents of the anti‑
CEA‑dBSA functionalized GFET caused by the control, 
10 pg mL−1, 100 pg mL−1, 1 ng mL−1, 5 ng mL−1, and 
45 ng mL−1 groups were 0.0747, 0.661, 1.01, 1.77, 2.73, 
and 4.99 μA, respectively. The dissociation constant (Kd) 
for the interaction between the anti‑CEA mAb and CEA 
could be estimated by measuring the drain current (Ids) of the 
anti‑CEA‑dBSA functionalized GFET at different CEA con‑
centrations. The quantity of net drain–source current (∆Ids) 
was calculated as a function of CEA protein concentrations, 
as shown in Fig. 5b. The plot of the data yielded a nonlinear 
curve, indicating that the relationship between ∆Ids and the 
binding CEA could fit the Hill adsorption model [55, 56] 
calculated as Eq. (4):
where Kd is the dissociation constant of the interaction 
between CEA and anti‑CEA mAb, ΔImax is the saturated 
net drain–source current, Ccea is the protein concentration, 
and n is the Hill cooperativity coefficient of the binding 
interaction.
According to the fitted red curve shown in Fig. 5b, ΔImax, 
Kd, and n were estimated to be 12.1 µA, 122.8 ng mL−1, 
and 0.35, respectively. The calculated value of n was less 
than 1, which indicated the negative cooperativity in binding 
interaction between CEA and anti‑CEA mAb. The molecular 
weight of CEA of approximately 180 kD [57] resulted in a 
dissociation constant of 6.82 × 10−10 M. The dissociation 
constant between CEA and anti‑CEA mAb had been inves‑
tigated previously [58, 59], and it was determined to vary 
from 4 × 10−12 to 1 × 10−7 M. Therefore, the value of the 
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Fig. 5  a Drain–source current of the anti‑CEA‑dBSA functionalized GFET in the presence of CEA concentrations of 10  pg  mL−1, 
100 pg mL−1, 1 ng mL−1, 5 ng mL−1, and 45 ng mL−1. b Net drain–source current at different CEA concentrations fitted with a curve (red line) 
of the Hill adsorption model. (Color figure online)
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anti‑CEA‑dBSA functionalized GFETs was in accordance 
with previously reported results, indicating a high affinity 
between CEA and anti‑CEA mAb. From Eq. (4) and the defi‑
nition of the dissociation constant (Kd) [60], while the ligand 
concentration was equal to the dissociation constant (Kd), 
the percentage of bound receptors at equilibrium was 50%. 
According to the calculated value (122.8 ng mL−1) of  Kd, the 
available receptors on the dBSA functionalized GFETs bio‑
interface were sufficient for the detection of CEA molecules 
under different concentrations in this study. According to 
the fitting results, the limit of detection was estimated to be 
approximately 337.58 fg mL−1, which was lower than for 
other graphene FET biosensors [41, 61, 62]. Well‑defined 
drain–source current changes were observed for low CEA 
concentrations (337.58 fg mL−1) in diluted serum, which 
were much smaller than the cutoff value (5 ng mL−1) used in 
clinical diagnosis. In addition, compared with other nanoma‑
terial‑based CEA immunosensors in Table S3, the sensitiv‑
ity of multifunctional dBSA functionalized GFETs showed 
obvious superiority. These results clearly demonstrated 
the promising potential of anti‑CEA‑dBSA functionalized 
GFETs in clinical applications.
4  Conclusions
A simple, convenient, and sensitive graphene–protein bio‑
electronic interface for GFETs based on a multifunctional 
nano‑dBSA functionalized process was designed to target 
cancer biomarkers in diluted serum. This multifunctional 
nano‑dBSA film formed on graphene acted as a protective 
layer and maintained the electronic properties of graphene 
during the fabrication of GFET devices and also served 
as a bifunctional cross‑linker to bioconjugate anti‑CEA 
mAb to detect CEA. This novel fabrication process made a 
high‑performance GFET biosensor possible, as evidenced 
by electronic and fluorescent characterization. Good speci‑
ficity and ultrahigh sensitivity (337.58 fg mL−1) toward 
CEA molecules were achieved by the measurement of 
drain–source currents of anti‑CEA mAb functionalized 
GFETs. Measured responses with different orders of mag‑
nitude in analytes concentration displayed a good fit to a 
model based on the Hill binding equation, which indicated 
the negative cooperativity and a strong affinity between 
CEA and anti‑CEA mAb binding interaction. Experimen‑
tal results verified that the sensor response was derived 
from specific binding of the receptor to CEA, indicating 
that this multifunctional nano‑dBSA film maintained its 
biologically active analyte‑binding configuration when 
noncovalently bound to graphene. By functionalizing such 
different 2D nanomaterials with related receptors by this 
nano‑dBSA process, it should be possible to offer control‑
lable functionalization methods for various bio‑interfaces 
for biosensors, nanomedicine, imaging, cancer therapy, 
and drug delivery.
Acknowledgements The authors are grateful to the support 
of grants from the National Key R&D Program of China (Nos. 
2018YFA0108202 and 2017YFA0205300), the National Natu‑
ral Science Foundation of China (Nos. 61571429, 61801464, 
61801465, and 81471748), the STS Project of the Chinese Acad‑
emy of Sciences (NO.KFJ‑STS‑SCYD‑120), the Science and Tech‑
nology Commission of Shanghai Municipality (Nos. 16410711800 
and 14391901900).
Open Access This article is distributed under the terms of the 
Creative Commons Attribution 4.0 International License (http://
creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted 
use, distribution, and reproduction in any medium, provided you 
give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons license, and indicate if 
changes were made.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4082 0‑019‑0250‑8) contains 
supplementary material, which is available to authorized users.
References
 1. J.D. Cohen, L. Li, Y. Wang, C. Thoburn, B. Afsari et al., 
Detection and localization of surgically resectable can‑
cers with a multi‑analyte blood test. Science 359, 926–930 
(2018). https ://doi.org/10.1126/scien ce.aar32 47
 2. R.L. Siegel, A. Jemal, R.C. Wender, T. Gansler, J. Ma et al., 
An assessment of progress in cancer control. CA‑Cancer 
J. Clin. 68(5), 329–339 (2018). https ://doi.org/10.3322/
caac.21460 
 3. Y. Cao, G. Mo, J. Feng, X. He, L. Tang et al., Based on ZnSe 
quantum dots labeling and single particle mode ICP‑MS cou‑
pled with sandwich magnetic immunoassay for the detection of 
carcinoembryonic antigen in human serum. Anal. Chim. Acta 
1028, 22e31 (2018). https ://doi.org/10.1016/j.aca.2018.04.039
 4. J.A. Baron, Screening for cancer with molecular markers: 
progress comes with potential problems. Nat. Rev. Cancer 
12(5), 368–371 (2012). https ://doi.org/10.1038/nrc32 60
 5. D. Xie, Y. Wang, J. Shen, J. Hu, P. Yin et al., Detection 
of carcinoembryonic antigen in peritoneal fluid of patients 
undergoing laparoscopic distal gastrectomy with complete 
Nano‑Micro Lett.           (2019) 11:20  Page 11 of 13    20 
1 3
mesogastric excision. Br. J. Surg. 105, 1471–1479 (2018). 
https ://doi.org/10.1002/bjs.10881 
 6. R. Elisei, A. Pinchera, Advances in the follow‑up of differenti‑
ated or medullary thyroid cancer. Nat. Rev. Endocrinol. 8(8), 
466–475 (2012). https ://doi.org/10.1038/nrend o.2012.38
 7. N. Laboria, A. Fragoso, W. Kemmner, D. Latta, O. Nilsson 
et al., Amperometric immunosensor for carcinoembryonic 
antigen in colon cancer samples based on monolayers of den‑
dritic bipodal scaffolds. Anal. Chem. 82, 1712–1719 (2010). 
https ://doi.org/10.1021/ac902 162e
 8. F. Yea, Y. Zhao, R. El‑Sayed, M. Muhammed, M. Hassan, 
Advances in nanotechnology for cancer biomarkers. Nano 
Today 18, 103–123 (2018). https ://doi.org/10.1016/j.nanto 
d.2017.12.008
 9. G. Nie, Y. Tang, B. Zhang, Y. Wang, Q. Guo, Label‑free pho‑
toelectrochemical immunosensing platform for detection of 
carcinoembryonic antigen through photoactive conducting 
poly(5‑formylindole) nanocomposite. Biosens. Bioelectron. 
116, 60–66 (2018). https ://doi.org/10.1016/j.bios.2018.05.041
 10. B. Liu, Y. Li, H. Wan, L. Wang, W. Xu et al., High perfor‑
mance, multiplexed lung cancer biomarker detection on a 
plasmonic gold chip. Adv. Funct. Mater. 26(44), 7994–8002 
(2016). https ://doi.org/10.1002/adfm.20160 3547
 11. J. Peng, Y.Q. Lai, Y.Y. Chen, J. Xu, L.P. Sun et al., Sensitive 
detection of carcinoembryonic antigen using stability‑limited 
few‑layer black phosphorus as an electron donor and a reser‑
voir. Small 13(15), 1603589 (2017). https ://doi.org/10.1002/
smll.20160 3589
 12. T. Wang, D. Qi, H. Yang, Z. Liu, M. Wang et al., Tactile che‑
momechanical transduction based on an elastic microstruc‑
tured array to enhance the sensitivity of portable biosensors. 
Adv. Mater. 31, 1803883 (2018). https ://doi.org/10.1002/
adma.20180 3883
 13. L. Duan, L. Yobas, Label‑free multiplexed electrical detection 
of cancer markers on a microchip featuring an integrated flu‑
idic diode nanopore array. ACS Nano 12, 7892–7900 (2018). 
https ://doi.org/10.1021/acsna no.8b022 60
 14. G. Jie, J. Ge, X. Gao, C. Li, Amplified electrochemilumi‑
nescence detection of CEA based on magnetic  Fe3O4@Au 
nanoparticles‑assembled Ru@SiO2 nanocomposites com‑
bined with multiple cycling amplification strategy. Biosens. 
Bioelectron. 118, 115–121 (2018). https ://doi.org/10.1016/j.
bios.2018.07.046
 15. Y. Zhou, S.H. Chen, X.L. Luo, Y.Q. Chai, R. Yuan, Ternary 
electrochemiluminescence nanostructure of Au nanoclusters 
as a highly efficient signal label for ultrasensitive detection of 
cancer biomarkers. Anal. Chem. 90(16), 10024–10030 (2018). 
https ://doi.org/10.1021/acs.analc hem.8b026 42
 16. G. Xu, J. Abbott, L. Qin, K.Y. Yeung, Y. Song et al., Elec‑
trophoretic and field‑effect graphene for all‑electrical DNA 
array technology. Nat. Commun. 5, 4866 (2014). https ://doi.
org/10.1038/ncomm s5866 
 17. J.E. Kim, Y.H. No, J.N. Kim, Y.S. Shin, W.T. Kang et al., 
Highly sensitive graphene biosensor by monomolecular self‑
assembly of receptors on graphene surface. Appl. Phys. Lett. 
110, 203702 (2017). https ://doi.org/10.1063/1.49830 84
 18. Y. Cui, Q. Wei, H. Park, C.M. Lieber, Nanowire nanosensors 
for highly sensitive and selective detection of biological and 
chemical species. Science 293, 1289–1292 (2001). https ://doi.
org/10.1126/scien ce.10627 11
 19. W.U. Wang, C. Chen, K.H. Lin, Y. Fang, C.M. Lieber, Label‑
free detection of small‑molecule–protein interactions by using 
nanowire nanosensors. Proc. Natl. Acad. Sci. USA 102, 3208 
(2005). https ://doi.org/10.1073/pnas.04063 68102 
 20. R.J. Chen, S. Bangsaruntip, K.A. Drouvalakis, N.W. Kam, M. 
Shim et al., Noncovalent functionalization of carbon nano‑
tubes for highly specific electronic biosensors. Proc. Natl. 
Acad. Sci. USA 100, 4984 (2003). https ://doi.org/10.1073/
pnas.08370 64100 
 21. G. Xu, J. Abbott, D.H. Ham, Optimization of CMOS‑ISFET‑
based biomolecular sensing: analysis and demonstration in 
DNA detection. IEEE Trans. Electron Devices 63, 3249–3256 
(2016). https ://doi.org/10.1109/TED.2016.25828 45
 22. M. Medina‑Sanchez, S. Miserere, A. Merkoci, Nanomaterials 
and lab‑on‑a‑chip technologies. Lab Chip 12, 1932 (2012). 
https ://doi.org/10.1039/c2lc4 0063d 
 23. J.A. Mann, T. Alava, H.G. Craighead, W.R. Dichtel, Preser‑
vation of antibody selectivity on graphene by conjugation to 
a tripod monolayer. Angew. Chem. Int. Ed. 52, 3177–3180 
(2013). https ://doi.org/10.1002/anie.20120 9149
 24. Y. Liu, X. Dong, P. Chen, Biological and chemical sensors 
based on graphene materials. Chem. Soc. Rev. 41, 2283–2307 
(2012). https ://doi.org/10.1039/C1CS1 5270J 
 25. T.P.D. Shareena, D. McShan, A.K. Dasmahapatra, P.B. 
Tchounwou, A review on graphene‑based nanomaterials in 
biomedical applications and risks in environment and health. 
Nano‑Micro Lett. 10, 53 (2018). https ://doi.org/10.1007/s4082 
0‑018‑0206‑4
 26. C. Wang, Y. Li, Y. Zhu, X. Zhou, Q. Lin, M. He, High‑κ‑solid‑
gate transistor configured graphene biosensor with fully inte‑
grated structure and enhanced sensitivity. Adv. Funct. Mater. 
26, 7668–7678 (2016). https ://doi.org/10.1002/adfm.20160 
2960
 27. V. Yadav, S. Roy, P. Singh, Z. Khan, A. Jaiswal, 2D 
 MoS2‑based nanomaterials for therapeutic, bioimaging, and 
biosensing applications. Small 15, 1803706 (2018). https ://
doi.org/10.1002/smll.20180 3706
 28. C.H. Naylor, N.J. Kybert, C. Schneier, J. Xi, G. Romero 
et al., Scalable production of molybdenum disulfide based 
biosensors. ACS Nano 10, 6173–6179 (2016). https ://doi.
org/10.1021/acsna no.6b021 37
 29. Y. Chen, R. Ren, H. Pu, J. Chang, S. Mao et al., Field‑effect 
transistor biosensors with two‑dimensional black phosphorus 
nanosheets. Biosens. Bioelectron. 89, 505–510 (2017). https 
://doi.org/10.1016/j.bios.2016.03.059
 30. E.N. Primo, M.J. Kogan, H.E. Verdejo, S. Bollo, M.D. Rubi‑
anes et al., Label‑free graphene oxide‑based surface plasmon 
resonance immunosensor for the quantification of galectin‑3, 
a novel cardiac biomarker. ACS Appl. Mater. Interfaces 10, 
23501–23508 (2018). https ://doi.org/10.1021/acsam i.8b030 39
 31. E. Morales‑Narváez, L. Baptista‑Pires, A. Zamora‑Gálvez, 
A. Merkoçi, Graphene‑based biosensors: going simple. 
 Nano‑Micro Lett.           (2019) 11:20   20  Page 12 of 13
https://doi.org/10.1007/s40820‑019‑0250‑8© The authors
Adv. Mater. 29, 1604905 (2017). https ://doi.org/10.1002/
adma.20160 4905
 32. J. Peña‑Bahamonde, H.N. Nguyen, S.K. Fanourakis, D.F. Rod‑
rigues, Recent advances in graphene based biosensor technol‑
ogy with applications in life sciences. J. Nanobiotechnol. 16, 
75 (2018). https ://doi.org/10.1186/s1295 1‑018‑0400‑z
 33. P. Bollella, G. Fusco, C. Tortolini, G. Sanzò, G. Favero et al., 
Beyond graphene: electrochemical sensors and biosensors 
for biomarkers detection. Biosens. Bioelectron. 89, 152–166 
(2017). https ://doi.org/10.1016/j.bios.2016.03.068
 34. Z. Zhu, An overview of carbon nanotubes and graphene for 
biosensing applications. Nano‑Micro Lett. 9, 25 (2017). https 
://doi.org/10.1007/s4082 0‑017‑0128‑6
 35. K.S. Novoselov, A.K. Geim, S.V. Morozov, D. Jiang, Y. Zhang 
et al., Electric field effect in atomically thin carbon films. 
Science 306, 666–669 (2004). https ://doi.org/10.1126/scien 
ce.11028 96
 36. V. Georgakilas, M. Otyepka, A.B. Bourlinos, V. Chandra, N. 
Kim et al., Functionalization of graphene: covalent and non‑
covalent approaches, derivatives and applications. Chem. Rev. 
112, 6156–6214 (2012). https ://doi.org/10.1021/cr300 0412
 37. S. Viswanathan, T.N. Narayanan, K. Aran, K.D. Fink, J. 
Paredes et al., Graphene–protein field effect biosensors: glu‑
cose sensing. Mater. Today 18, 513–522 (2015). https ://doi.
org/10.1016/j.matto d.2015.04.003
 38. M.T. Hwang, P.B. Landon, J. Lee, D. Choi, A.H. Mo et al., 
Highly specific SNP detection using 2D graphene electronics 
and DNA strand displacement. Proc. Natl. Acad. Sci. USA 
113, 7088–7093 (2016). https ://doi.org/10.1073/pnas.16037 
53113 
 39. S.K. Jang, J. Jang, W.S. Choe, S. Lee, Harnessing denatured 
protein for controllable bipolar doping of a monolayer gra‑
phene. ACS Appl. Mater. Interfaces 7, 1250–1256 (2015). 
https ://doi.org/10.1021/am507 246v
 40. N. Gao, T. Gao, X. Yang, X. Dai, W. Zhou et al., Specific 
detection of biomolecules in physiological solutions using 
graphene transistor biosensors. Proc. Natl. Acad. Sci. USA 
113, 14633–14638 (2016). https ://doi.org/10.1073/pnas.16250 
10114 
 41. W.Y. Fu, L. Jiang, E.P. van Geest, M.C. LimaL, G.F. Schnei‑
der, Sensing at the surface of graphene field‑effect transis‑
tors. Adv. Mater. 29, 1603610 (2017). https ://doi.org/10.1002/
adma.20160 3610
 42. S. Liu, Y. Fu, C. Xiong, Z. Liu, L. Zheng et al., Detection 
of bisphenol a using DNA‑functionalized graphene field 
effect transistors integrated in microfluidic systems. ACS 
Appl. Mater. Interfaces 10, 23522–23528 (2018). https ://doi.
org/10.1021/acsam i.8b042 60
 43. S.K. Tuteja, C. Ormsby, S. Neethirajan, Noninvasive label‑
free detection of cortisol and lactate using graphene embed‑
ded screen‑printed electrode. Nano‑Micro Lett. 10, 41 (2018). 
https ://doi.org/10.1007/s4082 0‑018‑0193‑5
 44. L. Zhou, K. Wang, Z. Wu, H. Dong, H. Sun et al., Investiga‑
tion of controllable nanoscale heat‑denatured bovine serum 
albumin films on graphene. Langmuir 32, 12623 (2016). https 
://doi.org/10.1021/acs.langm uir.6b032 96
 45. M. Hu, J. Yan, Y. He, H.T. Lu, L.X. Weng et al., Ultrasensi‑
tive, multiplexed detection of cancer biomarkers directly in 
serum by using a quantum dot‑based microfluidic protein 
chip. ACS Nano 4, 488–494 (2010). https ://doi.org/10.1021/
nn901 404h
 46. E. Stern, R. Wagner, F.J. Sigworth, R. Breaker, T.M. Fahmy 
et al., Importance of the Debye screening length on nanow‑
ire field effect transistor sensors. Nano Lett. 7, 3405–3409 
(2007). https ://doi.org/10.1021/nl071 792z
 47. Y. Ohno, K. Maehashi, K. Matsumoto, Chemical and bio‑
logical sensing applications based on graphene field‑effect 
transistors. Biosens. Bioelectron. 26, 1727–1730 (2010). 
https ://doi.org/10.1016/j.bios.2010.08.001
 48. F. Schwierz, Graphene transistors. Nat. Nanotechnol. 5, 
487–496 (2010). https ://doi.org/10.1038/nnano .2010.89
 49. L.H. Hess, M.V. Hauf, M. Seifert, F. Speck, T. Seyller et al., 
High‑transconductance graphene solution‑gated field effect 
transistors. Appl. Phys. Lett. 99, 033503 (2011). https ://doi.
org/10.1063/1.36144 45
 50. L.H. Hess, M. Jansen, V. Maybeck, M.V. Hauf, M. Seifert 
et al., Graphene transistor arrays for recording action poten‑
tials from electrogenic cells. Adv. Mater. 23, 5045–5049 
(2011). https ://doi.org/10.1002/adma.20110 2990
 51. D.B. Farmer, H.Y. Chiu, Y.M. Lin, K.A. Jenkins, F.N. Xia 
et al., Utilization of a buffered dielectric to achieve high 
field‑effect carrier mobility in graphene transistors. Nano 
Lett. 9, 4474 (2009). https ://doi.org/10.1021/nl902 788u
 52. H.L. Xu, Z.Y. Zhang, L.M. Peng, Measurements and 
microscopic model of quantum capacitance in gra‑
phene. Appl. Phys. Lett. 98, 133122 (2011). https ://doi.
org/10.1063/1.35740 11
 53. H.L. Xu, Z.Y. Zhang, S. Wang, X.L. Liang, L.M. Peng, 
Quantum capacitance limited vertical scaling of graphene 
field‑effect transistor. ACS Nano 5, 2340–2347 (2011). https 
://doi.org/10.1021/nn200 026e
 54. B.J. Casey, P. Kofinas, Selective binding of carcinoem‑
bryonic antigen using imprinted polymeric hydrogels. J. 
Biomed. Mater. Res. A 87, 359–363 (2008). https ://doi.
org/10.1002/jbm.a.31757 
 55. L.K. Koopal, W.H. Riemsdijk, J.D. Wit, M.F. Benedetti, 
Analytical isotherm equations for multicomponent adsorp‑
tion to heterogeneous surfaces. J. Colloid Interface Sci. 166, 
51–60 (1994). https ://doi.org/10.1006/jcis.1994.1270
 56. D. Ringot, B. Lerzy, K. Chaplain, J.P. Bonhoure, E. Auclair 
et  al., In vitro biosorption of ochratoxin A on the yeast 
industry by‑products: comparison of isotherm models. 
Bioresour. Technol. 98, 1812–1821 (2007). https ://doi.
org/10.1016/j.biort ech.2006.06.015
 57. A. Haggarty, C. Legler, M.J. Krantz, A. Fuks, Epitopes of car‑
cinoembryonic antigen defined by monoclonal antibodies pre‑
pared from mice immunized with purified carcinoembryonic 
antigen or HCT‑8R cells. Cancer Res. 46, 300–309 (1986)
 58. J.E. Morris, M.L. Egan, C.W. Todd, The binding of carci‑
noembryonic antigen by antibody and its fragments. Cancer 
Res. 35, 1804–1808 (1975)
Nano‑Micro Lett.           (2019) 11:20  Page 13 of 13    20 
1 3
 59. M. Nap, M.L. Hammarstrom, O. Bormer, S. Hammarstrom, 
C. Wagener et al., Specificity and affinity of monoclonal 
antibodies against carcinoembryonic antigen. Cancer Res. 
52, 2329–2339 (1992)
 60. H. Bjorkelund, L. Gedda, K. Andersson, Comparing the 
epidermal growth factor interaction with four different cell 
lines: intriguing effects imply dependency of cellular context. 
PLoS ONE 6(1), e16536 (2011). https ://doi.org/10.1371/journ 
al.pone.00165 36
 61. Y.M. Lei, M.M. Xiao, Y.T. Li, L. Xu, H. Zhang et al., Detec‑
tion of heart failure‑related biomarker in whole blood with gra‑
phene field effect transistor biosensor. Biosens. Bioelectron. 
91, 1–7 (2017). https ://doi.org/10.1016/j.bios.2016.12.018
 62. T. Berninger, C. Bliem, E. Piccinini, O. Azzaroni, W. Knoll, 
Cascading reaction of arginase and urease on a graphene‑
based FET for ultrasensitive, real‑time detection of argi‑
nine. Biosens. Bioelectron. 115, 104–110 (2018). https ://doi.
org/10.1016/j.bios.2018.05.027
